Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD
暂无分享,去创建一个
P. Nelson | J. Stöhr | S. Porta | M. Neumann | O. Adolfsson | A. Pfeifer | T. Seredenina | A. Bavdek | Elodie Chevalier | Alberto B. Silva | D. Havas | R. Moser | T. Ziehm | C. Dumayne | M. Kosco-Vilbois | M. Audrain | V. M. Lee | A. Egesipe | V. Eligert | T. Afroz | K. Piorkowska | Lorène Mottier | Mayank Chauhan | R. Ollier | Monisha Ratnam | Samjhana Thapa | E. Chevalier